According to GlobalData’s medical device pipeline database, 28 Positive Airway Pressure Devices devices are in various stages of development globally. GlobalData’s report provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, 14 are in active development, while the remaining 14 are in an inactive stage of development. There are four products in the early stages of development, and the remaining ten are in the late stages of development.
Positive airway pressure is a method of respiratory ventilation used primarily in the treatment of sleep apnea. PAP ventilation can also be used during the “weaning off” period of a ventilated intensive care patient, in exacerbations of Chronic Obstructive Pulmonary Disease (COPD), pulmonary edema and other settings of respiratory failure. PAP machines keep pressured air flowing through the airways of the throat. The patient wears a face mask which is attached to a tube and a machine that blows the pressurized air through mask into the airway and this air acts like a balloon keeping the windpipe open during sleep. Continuous Positive Airway Pressure (CPAP) devices, Bi-level Positive Airway Pressure (BPAP) devices, Automatic self-adjusting Positive Airway Pressure (APAP) devices are covered under this. One unit refers to One positive airway pressure device.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
See Also:
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Positive Airway Pressure Devices pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Positive Airway Pressure Devices devices. Overall, most of these Positive Airway Pressure Devices pipeline devices are being developed by private entities.
Key players involved in the active development of Positive Airway Pressure Devices include Fisher & Paykel Healthcare, RespiNova, Rhinomed, Sleep Secure, Tel Aviv University, Universitas Padjadjaran, Vincent Medical, Airing, Beijing Dehaier Medical Technology and Bhabha Atomic Research Centre.
For a complete picture of the developmental pipeline for Positive Airway Pressure Devices devices, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
